CO6351726A2 - Compuestos pirazolicos 436 - Google Patents
Compuestos pirazolicos 436Info
- Publication number
- CO6351726A2 CO6351726A2 CO11005446A CO11005446A CO6351726A2 CO 6351726 A2 CO6351726 A2 CO 6351726A2 CO 11005446 A CO11005446 A CO 11005446A CO 11005446 A CO11005446 A CO 11005446A CO 6351726 A2 CO6351726 A2 CO 6351726A2
- Authority
- CO
- Colombia
- Prior art keywords
- compounds
- pirazolic
- dimethoxyphenethyl
- pyrazol
- benzamide
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 2
- -1 3- (3,5-dimethoxyphenethyl) -1H-pyrazol-5-yl Chemical group 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Se proporcionan nuevos compuestos isómeros de N-(3-(3,5-dimetoxifenetil)-1H-pirazol-5-il)-4-(3, 4-dimetil piperazin -1-il) benzamida, de fórmula (la) o (Ib):aceptables de estos, procesos para su preparación, o sales farmacéuticamente composiciones farmacéuticas que los contienen y su uso en terapia.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7388308P | 2008-06-19 | 2008-06-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
CO6351726A2 true CO6351726A2 (es) | 2011-12-20 |
Family
ID=40935715
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CO11005446A CO6351726A2 (es) | 2008-06-19 | 2011-01-19 | Compuestos pirazolicos 436 |
Country Status (23)
Country | Link |
---|---|
US (1) | US20090318468A1 (es) |
EP (1) | EP2328872A1 (es) |
JP (1) | JP2011524888A (es) |
KR (1) | KR20110020904A (es) |
CN (1) | CN102123989A (es) |
AR (1) | AR072261A1 (es) |
AU (1) | AU2009261683A1 (es) |
BR (1) | BRPI0914233A2 (es) |
CA (1) | CA2728063A1 (es) |
CL (1) | CL2010001470A1 (es) |
CO (1) | CO6351726A2 (es) |
CR (1) | CR11857A (es) |
DO (1) | DOP2010000387A (es) |
EA (1) | EA201100030A1 (es) |
EC (1) | ECSP10010693A (es) |
IL (1) | IL210082A0 (es) |
MX (1) | MX2010014234A (es) |
PE (1) | PE20110062A1 (es) |
SV (1) | SV2010003767A (es) |
TW (1) | TW201002693A (es) |
UY (1) | UY31918A (es) |
WO (1) | WO2009153592A1 (es) |
ZA (1) | ZA201100471B (es) |
Families Citing this family (39)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9090601B2 (en) | 2009-01-30 | 2015-07-28 | Millennium Pharmaceuticals, Inc. | Thiazole derivatives |
US20120258940A1 (en) * | 2009-12-18 | 2012-10-11 | Giordano Caponigro | Method for treating haematological cancers |
US8754114B2 (en) | 2010-12-22 | 2014-06-17 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3 |
AU2013227139B2 (en) | 2012-02-28 | 2017-02-16 | Astellas Pharma Inc. | Nitrogen-containing aromatic heterocyclic compound |
CN107383009B (zh) | 2012-06-13 | 2020-06-09 | 因塞特控股公司 | 作为fgfr抑制剂的取代的三环化合物 |
US9388185B2 (en) | 2012-08-10 | 2016-07-12 | Incyte Holdings Corporation | Substituted pyrrolo[2,3-b]pyrazines as FGFR inhibitors |
US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
AR094812A1 (es) | 2013-02-20 | 2015-08-26 | Eisai R&D Man Co Ltd | Derivado de piridina monocíclico como inhibidor del fgfr |
PL403149A1 (pl) * | 2013-03-14 | 2014-09-15 | Celon Pharma Spółka Akcyjna | Nowe związki pochodne pirazolilobenzo[d]imidazolu |
US20160052926A1 (en) * | 2013-03-15 | 2016-02-25 | Hutchison Medipharma Limited | Novel pyrimidine and pyridine compounds and usage thereof |
CN105263931B (zh) | 2013-04-19 | 2019-01-25 | 因赛特公司 | 作为fgfr抑制剂的双环杂环 |
WO2015008844A1 (ja) | 2013-07-18 | 2015-01-22 | 大鵬薬品工業株式会社 | Fgfr阻害剤耐性癌の治療薬 |
DK3023100T3 (da) | 2013-07-18 | 2019-05-27 | Taiho Pharmaceutical Co Ltd | Antitumorlægemiddel til intermitterende administration af fgfr-hæmmer |
KR102344105B1 (ko) | 2014-08-18 | 2021-12-29 | 에자이 알앤드디 매니지먼트 가부시키가이샤 | 모노시클릭 피리딘 유도체의 염 및 이의 결정 |
US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
EP3617205B1 (en) | 2015-02-20 | 2021-08-04 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
WO2016134294A1 (en) | 2015-02-20 | 2016-08-25 | Incyte Corporation | Bicyclic heterocycles as fgfr4 inhibitors |
MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
CA2980888C (en) | 2015-03-31 | 2018-03-06 | Taiho Pharmaceutical Co., Ltd. | Crystal of 3,5-disubstituted benzene alkynyl compound |
KR20180118719A (ko) * | 2016-03-04 | 2018-10-31 | 다이호야쿠힌고교 가부시키가이샤 | 악성 종양 치료용 제제 및 조성물 |
US11883404B2 (en) | 2016-03-04 | 2024-01-30 | Taiho Pharmaceuticals Co., Ltd. | Preparation and composition for treatment of malignant tumors |
AR111960A1 (es) | 2017-05-26 | 2019-09-04 | Incyte Corp | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación |
AU2018317153B2 (en) | 2017-08-15 | 2021-12-23 | Cspc Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd. | FGFR inhibitor and medical application thereof |
DK3769765T3 (da) | 2018-03-19 | 2024-05-13 | Taiho Pharmaceutical Co Ltd | Farmaceutisk sammensætning indeholdende natriumalkylsulfat |
MX2020008610A (es) | 2018-03-28 | 2020-09-21 | Eisai R&D Man Co Ltd | Agente terapeutico para carcinoma hepatocelular. |
CN110317173B (zh) * | 2018-03-30 | 2022-10-11 | 上海奕拓医药科技有限责任公司 | 用作fgfr不可逆抑制剂的酰胺基吡唑类化合物 |
JP2021523118A (ja) | 2018-05-04 | 2021-09-02 | インサイト・コーポレイションIncyte Corporation | Fgfr阻害剤の塩 |
US11466004B2 (en) | 2018-05-04 | 2022-10-11 | Incyte Corporation | Solid forms of an FGFR inhibitor and processes for preparing the same |
WO2020185532A1 (en) | 2019-03-08 | 2020-09-17 | Incyte Corporation | Methods of treating cancer with an fgfr inhibitor |
CA3129665A1 (en) | 2019-03-21 | 2020-09-24 | Onxeo | A dbait molecule in combination with kinase inhibitor for the treatment of cancer |
US11591329B2 (en) | 2019-07-09 | 2023-02-28 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
AU2020366006A1 (en) | 2019-10-14 | 2022-04-21 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
US11566028B2 (en) | 2019-10-16 | 2023-01-31 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
KR20220098759A (ko) | 2019-11-08 | 2022-07-12 | 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) | 키나제 억제제에 대해 내성을 획득한 암의 치료 방법 |
BR112022010664A2 (pt) | 2019-12-04 | 2022-08-16 | Incyte Corp | Derivados de um inibidor de fgfr |
EP4069696A1 (en) | 2019-12-04 | 2022-10-12 | Incyte Corporation | Tricyclic heterocycles as fgfr inhibitors |
WO2021146424A1 (en) | 2020-01-15 | 2021-07-22 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
JP2024522189A (ja) | 2021-06-09 | 2024-06-11 | インサイト・コーポレイション | Fgfr阻害剤としての三環式ヘテロ環 |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57150846A (en) * | 1981-03-13 | 1982-09-17 | Konishiroku Photo Ind Co Ltd | Photographic element |
JPH0511414A (ja) * | 1991-07-02 | 1993-01-22 | Fuji Photo Film Co Ltd | ハロゲン化銀カラー写真感光材料 |
HU219131B (hu) * | 1991-10-18 | 2001-02-28 | Monsanto Co. | Módszer és fungicid készítmény növények torsgombabetegségének gátlására és a hatóanyagok |
HRP921338B1 (en) * | 1992-10-02 | 2002-04-30 | Monsanto Co | Fungicides for the control of take-all disease of plants |
US6271237B1 (en) * | 1997-12-22 | 2001-08-07 | Dupont Pharmaceuticals Company | Nitrogen containing heteromatics with ortho-substituted P1s as factor Xa inhabitors |
GB9823103D0 (en) * | 1998-10-23 | 1998-12-16 | Pfizer Ltd | Pharmaceutically active compounds |
DE60017115T2 (de) * | 1999-02-10 | 2005-12-08 | Mitsubishi Pharma Corp. | Amid-derivate und deren medizinische verwendung |
GEP20053476B (en) * | 1999-08-12 | 2005-03-25 | Upjohn Co | 3(5)-Amino-Pyrazole Derivatives, Process for Their Preparation and Their Use as Antitumor Agents |
ATE350044T1 (de) * | 1999-09-24 | 2007-01-15 | Smithkline Beecham Corp | Thrombopoietinmimetika |
HN2001000008A (es) * | 2000-01-21 | 2003-12-11 | Inc Agouron Pharmaceuticals | Compuesto de amida y composiciones farmaceuticas para inhibir proteinquinasas, y su modo de empleo |
US20040043904A1 (en) * | 2000-09-22 | 2004-03-04 | Hiroshi Yamaguchi | N-(4-pyrazolyl) amide derivatives, chemicals for agricultural and horticultural use, and usage of the same |
EP1844766B1 (en) * | 2000-12-18 | 2012-04-18 | Institute of Medicinal Molecular Design, Inc. | Inhibitors against the production and release of inflammatory cytokines |
US6878714B2 (en) * | 2001-01-12 | 2005-04-12 | Amgen Inc. | Substituted alkylamine derivatives and methods of use |
US20060111409A1 (en) * | 2002-06-05 | 2006-05-25 | Susumu Muto | Medicament for treatment of diabetes |
TW200407112A (en) * | 2002-06-05 | 2004-05-16 | Inst Med Molecular Design Inc | Immunity-related protein kinase inhibitors |
WO2003103665A1 (ja) * | 2002-06-06 | 2003-12-18 | 株式会社医薬分子設計研究所 | 抗アレルギー薬 |
WO2004007472A1 (ja) * | 2002-07-10 | 2004-01-22 | Ono Pharmaceutical Co., Ltd. | Ccr4アンタゴニストおよびその医薬用途 |
EP1542999A1 (en) * | 2002-08-01 | 2005-06-22 | Pharmacia & Upjohn Company LLC | 1h-pyrazole and 1h-pyrrole-azabicyclic compounds with alfa-7 nachr activity |
US20040220170A1 (en) * | 2003-05-01 | 2004-11-04 | Atkinson Robert N. | Pyrazole-amides and sulfonamides as sodium channel modulators |
US7115359B2 (en) * | 2003-07-25 | 2006-10-03 | Konica Minolta Medical & Graphic, Inc. | Photothermographic material |
US7432271B2 (en) * | 2003-09-02 | 2008-10-07 | Bristol-Myers Squibb Company | Pyrazolyl inhibitors of 15-lipoxygenase |
US20050165031A1 (en) * | 2003-11-13 | 2005-07-28 | Ambit Biosciences Corporation | Urea derivatives as ABL modulators |
US7652146B2 (en) * | 2004-02-06 | 2010-01-26 | Bristol-Myers Squibb Company | Process for preparing 2-aminothiazole-5-carboxamides useful as kinase inhibitors |
US7253204B2 (en) * | 2004-03-26 | 2007-08-07 | Methylgene Inc. | Inhibitors of histone deacetylase |
WO2005105780A2 (en) * | 2004-04-28 | 2005-11-10 | Vertex Pharmaceuticals Incorporated | Compositions useful as inhibitors of rock and other protein kinases |
US7737149B2 (en) * | 2006-12-21 | 2010-06-15 | Astrazeneca Ab | N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-(3,5-dimethylpiperazin-1-yl)benzamide and salts thereof |
-
2009
- 2009-06-17 MX MX2010014234A patent/MX2010014234A/es not_active Application Discontinuation
- 2009-06-17 CA CA2728063A patent/CA2728063A1/en not_active Abandoned
- 2009-06-17 PE PE2010001161A patent/PE20110062A1/es not_active Application Discontinuation
- 2009-06-17 EA EA201100030A patent/EA201100030A1/ru unknown
- 2009-06-17 JP JP2011514127A patent/JP2011524888A/ja active Pending
- 2009-06-17 BR BRPI0914233A patent/BRPI0914233A2/pt not_active Application Discontinuation
- 2009-06-17 KR KR1020117000437A patent/KR20110020904A/ko not_active Application Discontinuation
- 2009-06-17 WO PCT/GB2009/050684 patent/WO2009153592A1/en active Application Filing
- 2009-06-17 EP EP09766153A patent/EP2328872A1/en not_active Withdrawn
- 2009-06-17 CN CN2009801328063A patent/CN102123989A/zh active Pending
- 2009-06-17 AU AU2009261683A patent/AU2009261683A1/en not_active Abandoned
- 2009-06-18 UY UY0001031918A patent/UY31918A/es not_active Application Discontinuation
- 2009-06-18 TW TW098120493A patent/TW201002693A/zh unknown
- 2009-06-19 US US12/487,838 patent/US20090318468A1/en not_active Abandoned
- 2009-06-19 AR ARP090102262A patent/AR072261A1/es unknown
-
2010
- 2010-12-16 IL IL210082A patent/IL210082A0/en unknown
- 2010-12-17 EC EC2010010693A patent/ECSP10010693A/es unknown
- 2010-12-17 DO DO2010000387A patent/DOP2010000387A/es unknown
- 2010-12-17 CR CR11857A patent/CR11857A/es not_active Application Discontinuation
- 2010-12-17 SV SV2010003767A patent/SV2010003767A/es not_active Application Discontinuation
- 2010-12-17 CL CL2010001470A patent/CL2010001470A1/es unknown
-
2011
- 2011-01-18 ZA ZA2011/00471A patent/ZA201100471B/en unknown
- 2011-01-19 CO CO11005446A patent/CO6351726A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
UY31918A (es) | 2010-01-29 |
DOP2010000387A (es) | 2012-09-30 |
KR20110020904A (ko) | 2011-03-03 |
MX2010014234A (es) | 2011-03-25 |
CA2728063A1 (en) | 2009-12-23 |
CN102123989A (zh) | 2011-07-13 |
WO2009153592A1 (en) | 2009-12-23 |
EP2328872A1 (en) | 2011-06-08 |
CR11857A (es) | 2011-02-25 |
SV2010003767A (es) | 2011-05-20 |
TW201002693A (en) | 2010-01-16 |
AR072261A1 (es) | 2010-08-18 |
EA201100030A1 (ru) | 2011-08-30 |
JP2011524888A (ja) | 2011-09-08 |
CL2010001470A1 (es) | 2011-05-06 |
IL210082A0 (en) | 2011-02-28 |
BRPI0914233A2 (pt) | 2015-11-03 |
AU2009261683A1 (en) | 2009-12-23 |
ZA201100471B (en) | 2012-06-27 |
ECSP10010693A (es) | 2011-01-31 |
US20090318468A1 (en) | 2009-12-24 |
PE20110062A1 (es) | 2011-03-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO6351726A2 (es) | Compuestos pirazolicos 436 | |
DOP2012000310A (es) | Morfolinopirimidinas y su uso en terapia | |
UY32203A (es) | Amino pirimidinas y su uso en terapia | |
ECSP099706A (es) | Nuevos derivados de n-(8-heteroariltetrahidronaftalen-2yl) y n-(5-heteroarilcroman-3-il) carboxamida para el tratamiento del dolor | |
UY30610A1 (es) | Moduladores de mglur5 | |
MX2009011964A (es) | Derivados heterociclicos pirrolo-nitrogenosos, su preparacion y uso farmaceutico. | |
SV2008001369A (es) | Benzimidazoles | |
EA201001013A1 (ru) | Бис(сульфониламино)производные для применения в терапии | |
UY32156A (es) | Derivados sustituidos de la n2 - [1-(5 - fluoropirimidin -2-il) etil] - n4 - (1-metil - 1h-imidazol - 4 - il)) - pirimidina - 2,4 - diaminas y sus sales farmacéuticamente aceptables, proceso de preparación, composiciones conteniéndolos y aplicaciones. | |
CL2011001658A1 (es) | Compuestos derivados de sulfonamidas, moduladores de los canales de sodio; composición farmacéutica que los comprende; y su uso en el tratamiento del dolor. | |
UY33491A (es) | ?Derivados de sulfonamida y sus sales farmacéuticamente aceptables para uso en medicina?. | |
UY27516A1 (es) | Bencimidazoles | |
CR20120427A (es) | Derivados de pirazol como inhibidores de jak | |
UY28764A1 (es) | Compuestos poliheterocíclicos y su uso como antagonistas del receptor de glutamato metabotrópico | |
NI201000079A (es) | Algunos derivados de 2-pirazinona y su uso como inhibidores de elastasa de los neutrófilos. | |
UY29609A1 (es) | Derivados de benzamidina y usos relacionados de los mismos | |
CR11119A (es) | Derivados de indazol oxadiazol sustituidos para uso como agonistas esfingozina 1-fosfato (sip) | |
UY32464A (es) | Nuevos compuestos de indazol | |
UA107324C2 (uk) | Похідні 1,2,3-триазолу для застосування як інгібіторів стеароїл-coa десатурази | |
EA201070327A1 (ru) | Катехоламиновые производные и их пролекарства | |
UY30048A1 (es) | Derivados sustituidos de la n,2-(1h-benzimidazol-1-il) acetamida, composiciones farmacéuticas conteniéndolos, procesos de preparación y aplicaciones | |
ATE500222T1 (de) | Benzamid- und heteroarenderivate als cetp- inhibitoren | |
UY27852A1 (es) | Difenilazatidinonas cationicamente sustituidas, procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso. | |
UY30356A1 (es) | Derivados de 3-halo-n-(2.(4-fluorofenil)-4-oxobutil)-n-metil-5-(trifluorometil)benzamida y composiciones de los mismos. | |
UY31839A (es) | Compuestos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Application granted | ||
FD | Application lapsed |